Skip to main content
Log in

The disposition of biphenylacetic acid following topical application

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Plasma and synovial fluid concentrations of biphenylacetic acid were determined following application of 3 g of 3% biphenylacetic acid gel to one knee of patients suffering from rheumatoid arthritis.

The mean peak plasma concentration was 34 ng/ml. Synovial fluid concentrations tended to follow plasma concentrations but at a somewhat lower level, the mean peak synovial fluid concentration was 21 ng/ml. The average ratio of synovial fluid AUC (0–24 h) to plasma AUC (0–24 h) was 0.58, r=0.97.

Where patients had bilateral effusions, the concentration in the ipsilateral knee at each time point examined was not significantly different to that in the contralateral knee, suggesting that absorption was initially into the plasma and subsequently into the synovium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Cuisanaud G, Legheand J, Llorca G, Belkahia C, Lejeune E, Sassard J (1979) Pharmacokinetics of fenbufen in man. Eur J Clin Pharmacol 16: 59–61

    Google Scholar 

  • Furst DE (1985) Synovial fluid kinetics of non steroidal anti-inflammatory drugs. Agents Actions 17 [Suppl]: 65–77

    Google Scholar 

  • Kewar SS (1983) Pharmacological properties of fenbufen. J Am Med Assoc 250: 84–90

    Google Scholar 

  • Mizushima Y (1982) Basic and clinical study of produgs of nonsteroidal anti-inflammatory drugs. Pharmacology 25: [Suppl 1]: 39–45

    Google Scholar 

  • Robinson JR (ed) (1979) Sustained and controlled drug release drug delivery systems. Marcel Dekker. New York

    Google Scholar 

  • Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA (1959) Revision of diagnostic criteria in rheumatoid arthritis. Ann Rheum Dis 18: 49–53

    Google Scholar 

  • Sugawara Y, Ono H, Ueda R, Ishigami M, Kubodera T, Fujiwara H, Sato Y, Yamasaki K (1985) Percutaneous absorption and tissue distribution of L-141 topical agent. J Med Pharmacol 13 (in Japanese, translation supplied by Cyanamid Clinical Research International, Pearl River, NY, USA)

  • Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature N Biol 231: 232–235

    Google Scholar 

  • Dawson M, McGee CM, Brooks PM, Vine JH, Lacey E, Watson TR (1987) Quantitation of biphenylacetic acid in plasma and synovial fluid by gas chromatography/mass spectrometry/mass spectrometry. J Chromatogr 420: 129–134

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dawson, M., McGee, C.M., Vine, J.H. et al. The disposition of biphenylacetic acid following topical application. Eur J Clin Pharmacol 33, 639–642 (1988). https://doi.org/10.1007/BF00542502

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00542502

Key words

Navigation